Accurate Conformation-Dependent Molecular Electrostatic Potentials for High-Throughput In Silico Drug Discovery

被引:98
|
作者
Puranen, J. Santeri [1 ]
Vainio, Mikko J. [1 ]
Johnson, Mark S. [1 ]
机构
[1] Abo Akad Univ, Struct Bioinformat Lab, Dept Biochem & Pharm, FI-20520 Turku, Finland
基金
芬兰科学院;
关键词
partial charges; molecular electrostatic potential; conformation dependent; polarizable; electronegativity equalization; ELECTRONEGATIVITY EQUALIZATION METHOD; DERIVING ATOMIC CHARGES; EFFICIENT GENERATION; AM1-BCC MODEL; HARDNESS; PARAMETERIZATION; VALIDATION; ALGORITHM; DENSITY; SMILES;
D O I
10.1002/jcc.21460
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The atom-centered partial charges-approximation is commonly used in current molecular modeling tools as a computationally inexpensive alternative to quantum mechanics for modeling electrostatics. Even today, the use of partial charges remains useful despite significant advances in improving the efficiency of oh initio methods. Here, we report on new parameters for the EEM and SEKEEM electronegativity equalization-based methods for rapidly determining partial charges that will accurately model the electrostatic potential of flexible molecules. The developed parameters cover most pharmaceutically relevant chemistries, and charges obtained using these parameters reproduce the B3LYP/cc-pVTZ reference electrostatic potential of a set of FDA-approved drug molecules at best to an average accuracy of 13 +/- 4 kJ mol(-1); thus, equipped with these parameters electronegativity equalization-based methods rival the current best non-quantum mechanical methods, such as AM1-BCC, in accuracy, yet incur a lower computational cost. Software implementations of EEM and SEKEEM, including the developed parameters, are included in the conformer-generation tool BALLOON, available free of charge at http://web.abo.fi/fak/mnf/bkf/research/johnson/software.php. (C) 2009 Wiley Periodicals, Inc. J Comput Chem 31: 1722-1732, 2010
引用
收藏
页码:1722 / 1732
页数:11
相关论文
共 50 条
  • [41] High throughput molecular dynamics for drug discovery
    Nathaniel Stanley
    Gianni De Fabritiis
    In Silico Pharmacology, 3 (1)
  • [42] Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics
    Shembekar, Nachiket
    Chaipan, Chawaree
    Utharala, Ramesh
    Merten, Christoph A.
    LAB ON A CHIP, 2016, 16 (08) : 1314 - 1331
  • [43] High-throughput molecular docking for lead discovery.
    Joseph-McCarthy, D
    Alvarez, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U365 - U365
  • [44] High-throughput drug screens for amyotrophic lateral sclerosis drug discovery
    McGown, Alexander
    Stopford, Matthew John
    EXPERT OPINION ON DRUG DISCOVERY, 2018, 13 (11) : 1015 - 1025
  • [45] High-throughput screening in drug metabolism and pharmacokinetic support of drug discovery
    White, RE
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 : 133 - 157
  • [46] The potential of high-content high-throughput microscopy in drug discovery
    Starkuviene, V.
    Pepperkok, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (01) : 62 - 71
  • [47] ADMETox improves drug discovery rates - Combining with in silico modeling, in vitro testing, automation, and high-throughput screening
    Kamath, L
    GENETIC ENGINEERING NEWS, 2006, 26 (09): : 1 - +
  • [48] Conformation-dependent dynamics of macromolecular ions in the gas phase under an electrostatic field: A molecular dynamics simulation
    Tamadate, Tomoya
    Orii, Takaaki
    Higashi, Hidenori
    Otani, Yoshio
    Kumita, Mikio
    Seto, Takafumi
    AEROSOL SCIENCE AND TECHNOLOGY, 2019, 53 (03) : 260 - 267
  • [49] High-Throughput drug discovery of novel inhibitors of secretion.
    Satoh, A.
    Suzuki, H.
    Honjo, Y.
    Nishina, Y.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25
  • [50] High-throughput X-ray crystallography for drug discovery
    Blundell, TL
    Patel, S
    CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (05) : 490 - 496